MAPT and Alzheimer disease: However, unlike in AD human patients and tau transgenic mice, we did not find apparent neurofibrillary-tangle–like structures after Gallyas silver staining in Tau-dKI mice (Fig. 1N,O), suggesting that this new model recapitulates a relatively early stage of the disease, with pretangle formations.